Review
Copyright ©The Author(s) 2025.
World J Stem Cells. Jul 26, 2025; 17(7): 107212
Published online Jul 26, 2025. doi: 10.4252/wjsc.v17.i7.107212
Table 1 Effectiveness of mesenchymal stem cell biological therapy in various studies
Biological therapies
Effects
Ref.
TGF-β1MSC differentiation toward NP/chondrogenic phenotype and upregulation of ERK1/2 activity[38,51]
TGF-β3MSC differentiation to NPC and AFC in combination with BMP-2 and IGF-1[31,32,34,35,52,53]
BMP2Differentiation into NPCs with TGF-β3 and PRP[32,34,44,54]
BMP7MSC differentiation into NP-like cells via the Smad pathway[55]
IGF1MSC differentiation into NPC-like cells[48,49,56]
FGF2MSC differentiation into NPC-like cells[48,50,57]
Table 2 Effectiveness of mesenchymal stem cells-derived extracellular vesicles in biological therapy across various studies
Biological therapies
Effects
Ref.
NLRP3Exosomes play an anti-inflammatory role in pathological NPCs by suppressing inflammatory mediators and NLRP3 inflammasome activation[78]
MLK3Bone marrow MSCs-derived exosomes-packaged miR-142-3p alleviates NPCs injury through suppressing MAPK signaling by targeting MLK3[72]
RASSF5MSCs may suppress TNF-α-induced apoptosis, ECM degradation, and fibrosis deposition in NPCs through the delivery of miR-532-5p via targeting RASSF5[73]
Notch1Inhibition of the Notch1 pathway facilitates NPC exosome-induced differentiation of MSCs into NP-like cells in vitro[74]
PI3K and AKTExosomal miR-21 restrains PTEN and thus activates PI3K/AKT pathway in apoptotic NPCs[80]
AKT and ERKMSC-exosomes could attenuate ER stress-induced apoptosis by activating AKT and ERK signaling[81]
ZNF121Exo-antagomiR-4450 retarded damage of NPCs in vitro, alleviated IDD damage, and ameliorated gait abnormality in vivo[82]
ATF6MSC-exosomes reduced apoptosis and calcification of EPCs via regulation of the miR-31-5p/ATF6/ER stress pathway[83]